53
Participants
Start Date
May 5, 2015
Primary Completion Date
November 2, 2017
Study Completion Date
November 30, 2017
Omaveloxolone capsules, 2.5 mg
omaveloxolone capsules, 5 mg
omaveloxolone capsules, 10 mg
Placebo capsules
omaveloxolone capsules, 20 mg
omaveloxolone capsules, 40 mg
omaveloxolone capsules, 80 mg
omaveloxolone capsules, 160 mg
University of Pittsburgh, Pittsburgh
The Children's Hospital of Philadelphia, Philadelphia
Akron Children's Hospital, Akron
Insitute for Exercise & Environmental Medicine, Dallas
Baylor College of Medicine, Houston
University of Texas Medical School at Houston, Houston
UCLA, Los Angeles
Mass General Hospital, Boston
Neuromuscular Clinic, Rigshospitalet, University of Copenhagen, Copenhagen